U.S. Telecom Services and Carriers Stock News

Wondering if Boeing at around $198 is still a turnaround story worth backing or if the easy money has already been made? This breakdown will walk you through what the current price is really baking in. Despite a bumpy ride with a 1-week return of -1.9% and a flat-ish 2.0% over 30 days, the stock is still up 15.6% year to date and 19.7% over the last year. This hints that sentiment has quietly shifted even though the 5-year return is still -12.0%. Recent headlines have centered on Boeing's...

If you are wondering whether Archrock is still a smart buy after its big multi year run, or if most of the upside is already priced in, this breakdown will help you assess whether the current price tag makes sense. The stock has inched up 6.2% over the last week and 4.4% over the past month, while longer term holders have seen gains of 254.8% over three years and 277.2% over five years. Those moves have come as investors focus on Archrock's role in natural gas infrastructure and the broader...

Hinge Health (HNGE) has been quietly on the move, with shares up over 12% in the past month and more than 32% year to date, even though the past 3 months have remained choppy. See our latest analysis for Hinge Health. That mix of a 7 day share price return near 8 percent and a 30 day share price return above 12 percent, despite a weaker 90 day patch, suggests momentum in Hinge Health is quietly rebuilding as investors reassess its growth story and risk profile around the 49.69 dollar mark. If...

Netflix Stock Performance In Context Netflix (NFLX) has quietly slipped about 4% in the past day and roughly 10% over the past week, extending a near 18% pullback this month that is starting to test investors patience. See our latest analysis for Netflix. That slide comes after a strong run, with the share price still up modestly year to date while the three year total shareholder return above 200% shows the longer term momentum story remains very much intact. Given how quickly sentiment can...

If you are wondering whether Artisan Partners Asset Management is quietly turning into a value opportunity or if the market is pricing it just right, this article will walk through what the numbers are really saying. The stock has pulled back recently, down around 3.3% over the last week and 8.8% over the past month, even though the 3 year return is still a strong 56.7% and 5 year performance sits at 22.1%. That combination of a recent slide and still solid multi year gains has come...

NeoGenomics, Inc. recently highlighted new clinical data on its RaDaR® 1.0 molecular residual disease assay in early breast cancer and its Neo Comprehensive Myeloid genomic profiling panel at major oncology and hematology conferences, including SABCS 2025 and ASH 2025. These presentations underscore how NeoGenomics’ tumor-informed ctDNA testing and comprehensive genomic profiling may sharpen cancer recurrence monitoring, diagnostic accuracy, and treatment selection across solid tumors and...

Masco Corporation has announced that Group President of Decorative Architectural Products Imran Ahmad will leave on December 31, 2025, as his role is eliminated, while a new Executive Committee structure takes effect on January 1, 2026, consolidating oversight of key business units under President & CEO Jon Nudi and other senior leaders. This reshaped leadership model, including Jai Shah’s expanded Plumbing & Wellness remit and the addition of incoming Chief Human Resource Officer Jen Stone,...

SharkNinja has tapped into a fresh growth engine with Shark Beauty becoming the top skincare facial device brand in the U.S., powered by CryoGlow’s rapid adoption and the new FacialPro Glow system. See our latest analysis for SharkNinja. At a share price of $113.27, SharkNinja’s 1 month share price return of 22.88% and year to date share price return of 16.70% suggest momentum is building as investors price in the new beauty growth leg alongside its broader appliance franchise. If this kind...

In recent days, Amkor Technology was selected by Intel to handle EMIB advanced packaging work for the first time and also reported stronger-than-expected third-quarter results, while a 2023 Grantor Retained Annuity Trust linked to Susan Y Kim disclosed gifting 758,000 shares, leaving 725,000 shares held directly. Together, the new Intel business and the insider share transfer highlight how Amkor’s role in advanced packaging is expanding even as ownership stakes evolve. We’ll now look at how...

Las Vegas Sands (LVS) just topped expectations in its third quarter, with revenue up about 24% year over year and adjusted EPS jumping more than 75%, helped by standout strength at Marina Bay Sands. See our latest analysis for Las Vegas Sands. Even after that earnings beat, Las Vegas Sands shares trade around $66.47, with a roughly 21.5% 90 day share price return and a 24.7% one year total shareholder return. This suggests positive momentum as investors reassess growth in Asia focused resorts...

If you are wondering whether AGNC Investment is still a smart income play at today's price, or if most of the upside has already been taken, this breakdown is for you. After closing around $10.38, the stock has quietly climbed 11.9% year to date and is up 25.4% over the last year, despite some short term noise, with a 1.3% gain over 30 days and a small 0.8% dip in the last week. Recent headlines have focused on shifting interest rate expectations and the ripple effects across mortgage REITs,...

Argan (AGX) just posted another jump in profits for its third quarter and nine month results, even as quarterly sales slipped slightly. That mix of margin strength and discipline is what has investors leaning in. See our latest analysis for Argan. Even with a recent pullback, including a 7 day share price return of negative 7.21 percent, Argan’s 90 day share price return of 40.06 percent and three year total shareholder return of 868.35 percent suggest momentum is still firmly in its corner...

Mettler-Toledo International recently reported past third-quarter results that exceeded analyst expectations, with revenue rising 7.9% year over year and adjusted EPS improving 9.2%, underscoring resilient demand for its precision instruments across regulated industries. Alongside this earnings beat, sustained analyst optimism and fresh coverage updates highlight how Mettler-Toledo’s market leadership and diversified global footprint remain central to its long-term growth story. With this...

We wouldn't blame KKR Real Estate Finance Trust Inc. ( NYSE:KREF ) shareholders if they were a little worried about the...

If you are wondering whether Navient is quietly turning into a value opportunity or just another value trap, you are not alone. That is exactly what we are going to unpack. Despite being down about 10.9% over the last year and 13.1% over three years, the stock has recently shown some life, with a 3.1% gain over the past week and an 8.9% move over the last month. This hints that market sentiment might be shifting. Recent headlines around federal student loan policies, shifting repayment...

Wondering if Arlo Technologies at around $14 is still a smart buy, or if most of the upside has already been priced in? You are not alone in asking whether the current tag matches the real value of the business. The stock is up 0.6% over the last week, down 8.9% over the past month, but still up 30.9% year to date and 331.2% over 3 years. This mix hints at both strong long term momentum and shifting risk perceptions in the short term. Those swings have come as Arlo continues to refine its...

Conagra Brands (CAG) is back in the spotlight after a fresh analyst downgrade put its inflation challenges, slow growth, and sizable debt load under the microscope, even as management highlights what it describes as meaningful recent net debt reduction. See our latest analysis for Conagra Brands. At a share price of $17.44, Conagra’s 1 day share price return of 1.87 percent and 1 month share price return of 2.71 percent look like a modest bounce within a much weaker backdrop. Its 1 year total...

Wondering if DXC Technology at around $15 a share is a value trap or a quiet opportunity? This piece will walk through what the numbers are really saying about the stock. Despite being down 23.4% year to date and 29.9% over the last year, the stock has bounced about 10.4% in the past week and 11.8% over the last month, hinting that sentiment might be starting to shift. That rebound has come as investors digest ongoing portfolio reshaping, cost cutting efforts and strategic reviews across...

If you are wondering whether Lam Research is still worth buying after its massive run, you are not alone. This article is going to focus squarely on what the current price implies about future returns. The stock has climbed 5.3% over the last week, 1.1% over the last month, and an eye catching 132.3% year to date, adding to a 117.1% gain over the past year and 270.8% over three years. That kind of performance has pushed Lam firmly into the market spotlight, with investors increasingly...

If you are looking at Insmed and wondering whether the huge run up has already priced in the story, you are not alone. This article will walk through what the numbers are really saying about value from here. The stock has cooled off a bit in the very short term, slipping 8.2% over the last week and 1.1% over the last month, but that comes after an eye catching 171.4% gain year to date and 849.7% over three years. Recent momentum has been fueled by investor optimism around Insmed's late stage...

Chewy reported past third-quarter 2025 results showing net sales rising to US$3,116.6 million and net income improving to US$59.2 million, while also issuing fourth-quarter guidance and narrowing full-year 2025 sales expectations to about US$12.58–US$12.60 billion, implying roughly 8% adjusted year-over-year growth. The quarter underscored the growing weight of Chewy’s Autoship subscriptions and newer health services, as these higher-engagement offerings helped lift profitability and...

Wondering if Ouster's huge run means you are late to the party or staring at an overlooked opportunity? Let's break down what the market is really pricing in here. The stock is up 108.3% year to date and 181.4% over the last year, even after a recent 1.0% dip over 7 days and a modest 3.7% gain across 30 days. This hints that sentiment has shifted fast, and risk perceptions are clearly changing. Much of this excitement has been driven by Ouster's push to scale its lidar technology into...

It looks like Merck & Co., Inc. ( NYSE:MRK ) is about to go ex-dividend in the next three days. The ex-dividend date...

If you have been wondering whether Old Dominion Freight Line is a bargain or just fairly priced right now, you are not alone. This article is going to tackle that question head on. After a tough stretch that still leaves the stock down around 10.5% year to date and 22.0% over the last year, the recent 12.8% rise over 30 days and 2.5% gain in the last week suggest sentiment might be starting to turn. Recent headlines around the less than truckload sector have focused on shifting freight...